Latest in News & Research

From Poster to Practice: Remibrutinib Around Procedures

A procedure can turn an otherwise routine CSU follow-up into a different kind of treatment conversation. Drawing from a post hoc analysis of REMIX-1...

| October 23, 2026

What Patients Do With the Prescription

A prescription tells us what treatment was recommended, but not always how it is being used. Survey findings from adults and caregivers managing psoriasis,...

| October 29, 2026

What Clearance Doesn't Capture

For patients with genital psoriasis, disease burden can extend well beyond what conventional severity scores reflect. Intimacy, personal relationships, and sexual function may be...

| October 29, 2026

When GLP-1s Enter the Psoriasis Treatment Picture

As GLP-1–based medications become increasingly common, their potential effects on other therapies are drawing greater attention. For oral psoriasis treatments, concerns about altered gastrointestinal...

| October 29, 2026

The Gap Between Prescribing and Control

Treating a flare and keeping disease under control are not necessarily the same thing. In a survey of adults and caregivers managing chronic inflammatory...

| October 29, 2026

Scalp and Body, Side by Side

Psoriasis may affect the scalp and body simultaneously, but treating these anatomically distinct areas presents different challenges. An analysis of the phase 3 ARRECTOR...

| October 29, 2026

ESMO: Adding mRNA-Based Cancer Vaccine Beneficial in Melanoma

Adding intismeran to pembrolizumab linked to reduced risk for recurrence, death for surgically resected melanoma
By Elana Gotkine (HealthDay News) | | October 28, 2026

Multisite Remission Explored in Multisite Mucous Membrane Pemphigoid

45 percent achieved multisite complete remission; persistent oral and ocular diseases frequently prevented remission
By Dermsquared Editorial Team | | October 28, 2026

The Distance Between Habit and Strategy

Topical therapy has changed considerably over the past decade, and prescribing, according to three years of claims data, has barely noticed.

By Dermsquared Editorial Team | | October 23, 2026

From Poster to Practice: The Control Gap in CIndU

Knowing the trigger may not mean controlling the disease. Using real-world data from the Chronic Urticaria Registry, this experience looks at how patients with...

| October 23, 2026

EADV: Oral Zasocitinib Beneficial for Adults With Plaque Psoriasis

Skin clearance superior across multiple end points compared with deucravacitinib; improvements also seen in QoL score, Itch NRS
By Dermsquared Editorial Team | | October 21, 2026

Intervention for Children of Skin Cancer Survivors Can Improve Sun-Protective Behaviors

However, no lasting reduction seen in child-reported sunburn with the intervention
By Dermsquared Editorial Team | | October 21, 2026

Minibeam Radiotherapy Promising for Cutaneous, Soft Tissue Malignancies

86 percent of the 36 patients with 46 lesions had symptomatic improvement with MBRT
By Elana Gotkine (HealthDay News) | | October 21, 2026

Poorer Maternal Diet Quality Linked to Infantile Colic, Eczema

Seafood intake was associated with significantly lower odds of colic and eczema combined
By Elana Gotkine (HealthDay News) | | October 21, 2026

1990 to 2023 Saw Increase in Global Burden of Acne

Burden is projected to continue increasing, reaching 37.5 million incident cases and 1.65 million DALYs globally by 2050
By Elana Gotkine (HealthDay News) | | October 21, 2026

Spatial Frequency Domain Imaging Offers Noninvasive Measure in Systemic Sclerosis

Diffuse reflectance and reduced scattering coefficient were significantly lower in systemic sclerosis versus control cohort
By Elana Gotkine (HealthDay News) | | October 21, 2026

When CSU Is Still in Control

In CSU, fewer hives do not always mean better control, especially when patients have learned to live around persistent itch, flares, and disruption.

By Dermsquared Editorial Team | | October 16, 2026

Chronic Immune-Related AEs Common in Patients With Melanoma Receiving Anti-PD-1 Therapy

Odds of chronic immune-related adverse events increased for corticosteroid-treated patients with earlier-onset irAEs
By Dermsquared Editorial Team | | October 11, 2026

EADV: Autonomous AI Can Increase Clinical Capacity for Dermatologists

Routine follow-up reduced with autonomous AI versus standard teledermatology; biopsy rate reduced versus face-to-face care
By Elana Gotkine (HealthDay News) | | October 11, 2026

Lower Dietary Diversity in First Year Linked to Atopic Dermatitis

Low- and moderate-diversity groups had significantly increased risk for AD compared with high-diversity group
By Elana Gotkine (HealthDay News) | | October 11, 2026

Atopic Dermatitis and What Familiarity Can Miss

At Fall Clinical 2026, familiar presentations of atopic dermatitis invite another look at diagnosis, burden, and the point when the usual approach stops being...

By Dermsquared Editorial Team | | October 06, 2026

IBD Events Rare in Patients With Hidradenitis Suppurativa Treated With IL-17 Inhibitors, Placebo

No significant difference seen in IBD events between patients treated with IL-17 inhibitors or placebo

By Dermsquared Editorial Team | | September 11, 2026

Margin-Controlled Surgery Beneficial for Immunosuppressed With Cutaneous SCC

Risk for any poor outcomes and major poor outcomes reduced with MMS/PDEMA versus SEVMA

By Dermsquared Editorial Team | | September 11, 2026

24 of 1300

Headline from the Week of November 02 - 08, 2026

Passive Tobacco Smoke Exposure Linked to Nonallergic Atopic Dermatitis Severity in Young Children

By Lori Solomon (HealthDay News) | | November 06, 2026

Patients With Psoriasis Have Increased Risks for Cataracts, Cataract Surgery

By Elana Gotkine (HealthDay News) | | November 06, 2026